Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma

PURPOSE: Recently a combination of paclitaxel and carboplatin (TC) (without an anthracycline) has begun to be used as an adjuvant or remission induction therapy, without any critical supportive evidence of its efficacy relative to a combination chemotherapy of taxane, platinum and anthracycline such...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fujiwara, Kazuko, Egawa-Takata, Tomomi, Ueda, Yutaka, Kimura, Toshihiro, Yoshino, Kiyoshi, Fujita, Masami, Miyatake, Takashi, Ohta, Yukinobu, Kamiura, Shoji, Enomoto, Takayuki, Kimura, Tadashi
Format: Artigo
Langue:Inglês
Publié: Springer-Verlag 2011
Sujets:
Gynecologic Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325403/
https://ncbi.nlm.nih.gov/pubmed/22127553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00404-011-2154-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires